Dr. Timothy Bailey, MD, the Institute’s director, said, “We are constantly exploring new pathways to diabetes management. This study is designed to treat people with type 2 diabetes who are taking a medication, but whose blood sugar is not controlled despite their treatment.”
Volunteers may be eligible for the study if they are being treated with metformin and sulfonylurea (such as: Glimepiride, Glipizide, or Glybruide) and still have uncontrolled blood sugar levels. Participants must be at least 18 years old and will receive study-related physical examinations, laboratory tests and study drugs at no cost, and may be compensated for their time and travel.
For more information and to volunteer for this study, contact AMCR Institute at 877-567-2627 or visit www.amcrinstitute.com.
# # #
About AMCR Institute: With clinics in Escondido and Temecula, AMCR Institute is a clinical research center focusing on Phase 2 to 3 trials in diabetes. AMCR Institute’s exceptional investigators and professional research coordinators are committed to providing superior service to our volunteer patients and sponsors. For information call 877-567-2627 or visit www.amcrinstitute.com.